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Introduction {#sec001}
============

Throughout their domestication process, animals have had great importance in human life, having been used for transport and hunting since ancient civilizations in all cultures. Furthermore, the biophilia hypothesis suggests that there is an innate human biological tendency to interact and form close connections and emotional bonds with other forms of natural life, especially with animals, starting in early childhood \[[@pone.0194731.ref001]--[@pone.0194731.ref004]\].

Human behaviour towards animals is complex and involves evolutionary, psychological, and cultural factors. The phylogenetic proximity and/or the physical, behavioural, and cognitive similarities between humans and other animals are only some of the factors that facilitate this relationship\[[@pone.0194731.ref005]\]. Other factors, such as the animal's aesthetics, its anthropomorphic characteristics and its child-like morphological and behavioural traits, stand out among those that increase animals' attractiveness to humans, especially to children, \[[@pone.0194731.ref006]--[@pone.0194731.ref008]\].

It is also worth noting that according to a study by Nagasawa et al. \[[@pone.0194731.ref009]\], companion animals, especially dogs, can contribute to the establishment of a human-animal bond that is behaviourally and neurohormonally similar to the mother-baby relationship. For these and other researchers, the psychological and psychophysiological effects associated with human-animal interactions also result from the activation of the oxytocinergic system and/or the facilitation of human-human relations (the so-called "social catalyst effect") \[[@pone.0194731.ref009]--[@pone.0194731.ref010]\].

Recognition of the positive aspects of this mutual interspecies relationship has prompted some scholars to investigate the use of animals in promoting human health. Currently, the International Association of Animal-Interaction Organizations (IAHAIO) has standardized theoretical, practical, and ethical guidelines related to different forms of intervention involving human-animal interaction\[[@pone.0194731.ref011]\].

One of these techniques is Animal Assisted Therapy (AAT), which is "*a goal oriented*, *planned and structured therapeutic intervention directed and/or delivered by health*, *education and human service professionals*. *(...) AAT is delivered and/or directed by a formally trained (with active licensure*, *degree or equivalent) professional with expertise within the scope of the professionals' practice*. *AAT focuses on enhancing physical*, *cognitive*, *behavioral and/or socio-emotional functioning of the particular human recipient*" \[[@pone.0194731.ref011]\] (p.5).

Scientific studies on AAT, particularly those involving dogs, have shown an openness to and an acceptance of this strategy by medical teams\[[@pone.0194731.ref012]--[@pone.0194731.ref018]\] and have documented recognition for AAT's safety and efficacy in different environments and clinical contexts, including hospitalization\[[@pone.0194731.ref019]--[@pone.0194731.ref021]\], emergency medicine\[[@pone.0194731.ref017]\], oncology\[[@pone.0194731.ref022]--[@pone.0194731.ref029]\], cardiology\[[@pone.0194731.ref018],[@pone.0194731.ref030]\], psychiatry\[[@pone.0194731.ref031]--[@pone.0194731.ref033]\], and outpatient and hospital paediatrics\[[@pone.0194731.ref034]--[@pone.0194731.ref038]\].

The results of studies on AAT are promising despite the lack of standardization of the number, duration, and frequency of sessions, the executed activities, and the safety measures for the animals and patients. Overall, the results indicate improvements in haemodynamic and physiological parameters\[[@pone.0194731.ref020],[@pone.0194731.ref030]\] and decreases in the prescription of analgesics\[[@pone.0194731.ref021]\] and perceived pain\[[@pone.0194731.ref020]\]. Regarding psychosocial variables, there is evidence of improved mood\[[@pone.0194731.ref034]\] and reduced symptoms of depression and anxiety\[[@pone.0194731.ref019],[@pone.0194731.ref020]\].

The use of AAT in the oncological context has been reported in several studies in adult populations\[[@pone.0194731.ref022]--[@pone.0194731.ref026],[@pone.0194731.ref029]\]. These studies have indicated improvements in anxiety and stress and an increased sense of well-being in addition to providing a distraction in the hospital setting. Qualitative studies from a single research group involving children\[[@pone.0194731.ref027],[@pone.0194731.ref028]\] have indicated an improvement in the acceptance of invasive procedures, improvement of the sense of well-being during hospitalization, reduction of depressive symptoms, and better adaptation to proposed therapies. However, no experimental quantitative studies have evaluated the effect of AAT in children to date.

In this context, the present study is a pioneer in the field of outpatient paediatric oncology in Brazil. The objectives of this study are a) to propose an intervention and safety protocol for the implementation of AAT and b) to evaluate the impact of an AAT programme in children undergoing outpatient oncological treatment based on psychological, physiological, and quality of life indicators for the children and caregivers.

Materials and methods {#sec002}
=====================

This study used a quasi-experimental design\[[@pone.0194731.ref039]\] and was approved by the local ethics committees in animal research (Comitê de Ética no Uso de Animais do IRCAD América Latina---Process No. 054/2015) and human research (Comitê de Ética em Pesquisa--Fundação Pio XII--Hospital de Câncer de Barretos---Process No. 1009960).

Participants {#sec003}
------------

This convenience sample was not estimated statistically. The participants evaluated for eligibility for the study (n = 4983) were in outpatient care at a children's oncology hospital from June 2015 to January 2017. Of these patients, 24 were selected because they met the inclusion and exclusion criteria.

The inclusion criteria were as follows: a) Both genders aged 6 to 12 years; Diagnosis of a solid tumour; b) Diagnosis of acute lymphoid leukaemia (in maintenance treatment in phase B of the RELLA B and RELLA T protocols, both starting at week 53 of maintenance B, and in the maintenance phase of the BFM 2002 protocol) ^\[^[@pone.0194731.ref040]^,^[@pone.0194731.ref041]^\]^; c) Undergoing outpatient oncological treatment; and d) Showing a good clinical status after evaluation, with authorization to participate in the study by the responsible physician.

The exclusion criteria were as follows: a) Children who were not interested in the intervention and/or were afraid of animals; b) Children with severe mental/cognitive problems that might lead to injuries/inconvenience to the animals and increase the likelihood of undesired events; c) Allergy to animals; d) Unavailability to participate in the sessions and/or nonattendance at the initial evaluation session; e) Inability to respond to the instruments; and f) Non-completion of the AAT programme.

In addition to these criteria, specific exclusion criteria were adopted for the children\'s participation in each session to increase the safety level of the study and to propose an eligibility protocol for intervention in this specific context; to the best of our knowledge, these criteria have not been described in detail in previous studies.

In this context, before participation in each AAT session, the children were evaluated by a nurse, and those who fit the following criteria were excluded: a) Isolation precaution; b) Presence of a surgical wound (suture, dehiscence, or drainage); c) Use of invasive devices (probe, catheter, or drain); d) Presence of ostomies; e) No current blood count available for evaluation; f) Neutropaenia (less than 500/mm^3^ or less than 1000/mm^3^ with likelihood of decreasing within the next 48 hours); g) Presence of severe infection, documented infection by resistant bacteria (*Staphylococcus aureus* or coagulase-negative oxacillin-resistant *S*. *aureus*, vancomycin-resistant *Enterococcus*, or cefepime-resistant and/or meropenem-resistant Gram-negative bacillus), or suspected or confirmed infection with *Clostridium difficile*; h) Fever, diarrhoea, vomiting, or respiratory symptoms during the week before the intervention; and i) Hospitalization or scheduled surgery.

The flowchart of the inclusion and exclusion criteria for the study participants is shown in [Fig 1](#pone.0194731.g001){ref-type="fig"} ([Fig 1](#pone.0194731.g001){ref-type="fig"}).

![Flowchart of the inclusion and exclusion criteria.](pone.0194731.g001){#pone.0194731.g001}

A specific protocol for animal entry and handling in the hospital setting was created that complied with the guidelines for animal-assisted interventions in health care facilities\[[@pone.0194731.ref042]\]. The adopted parameters were as follows:

1.  All individuals, whether targets of the intervention or members of the technical team, should wash their hands with water, soap, or alcohol every time they come into contact with the dogs;

2.  The animals were temporarily suspended from activities if, within 7 days prior to the intervention, they presented with i) stress, fatigue, and/or aggression, ii) oestrus, immunodepression, infections, or open wounds, or iii) episodes of diarrhoea, vomiting, or urinary/faecal incontinence. In cases in which this last condition occurred during the session, the Hospital Infection Commission was consulted to provide care for the children who had come into contact with the animals;

3.  In the event of a sphincter-related accident, the site should be properly cleaned, and the Hospital Infection Commission should be notified accordingly. In this situation, the animal should be re-educated to prevent the occurrence of such accidents;

4.  Possible episodes of bites and/or scratches of the participants by the dogs should be reported to the medical and nursing staff and later to the Hospital Infection Commission, and hygiene and care measures should be provided by the whole team;

5.  Prohibition of entry of the animal into specific hospital areas, such as kitchens and drug preparation areas. The animals were only allowed to enter the therapy room; and

6.  Dog hygiene should also include bathing, hair brushing, nail trimming, flea and tick monitoring (for a minimum of 24 hours before the session), and disinfection/cleaning of the dog's paws before and after the session with 70% alcohol.

Animals and handler {#sec004}
-------------------

One Labrador retriever and one golden retriever who were both healthy and carefully selected for this study were used for the intervention, because they met the following criteria: a) Docility, obedience training, and socialization; b) Approval of veterinary surgeons and animal behaviour specialists (trainers) after specific evaluation; c) Updated immunization records and anti-parasitic treatment; d) Quarterly clinical examinations (haematological and biochemical) by a veterinarian; e) Exclusive feeding on animal feed (dry food).

The handler was a physical therapist (NBA) with additional academic training in AAT who was also the owner of the animals. The animals and the handler had prior experience in this type of activity.

Intervention {#sec005}
------------

The AAT programme consisted of three 30-min sessions per week. The intervention occurred in an open group with a maximum of seven participants. The number of planned absences per participant was one, and the lost session needed to be replaced to complete a total of three sessions in a maximum of 4 weeks.

The activities carried out during the intervention were previously planned by the person delivering the intervention, who chose among the following per appropriateness for each session and depending on the interests and dynamics of the group: 1) sensorial and upper limb stimulation (brush, pet, and play fetch with the dog); 2) training on activities of daily living (give water and food to the food) and gait (walking with the dog); 3) socialization and recreation (dog show; playing with the dog's supplies; dog drawing; agility courses---guide the dog through obstacles such as cones and ropes; dog clothes---form words that express feelings and attach them to the dog clothes with Velcro; stories about the dog---daily routine, origin).

Instruments {#sec006}
-----------

The following self-applied instruments were used to evaluate outcome variables in the children:

1.  Child Stress Symptoms Inventory: This instrument is composed of 35 items that evaluate the occurrence or not of stress in children. The instrument was proposed and validated by Lipp et al\[[@pone.0194731.ref043],[@pone.0194731.ref044]\], and the original version was in Brazilian Portuguese. The items were self-administered, scored on a five-point Likert scale, and recorded in quarter circles according to the frequency with which the participants presented the symptoms described in each item as follows: never (0 points); rarely (1 point); sometimes (2 points); usually (3 points); and always (4 points). The maximum achievable score was 140 points.

2.  Quality of Life Evaluation Scale: The instrument is used to evaluate the quality of life in children aged 4 to 17 years. It is composed of 26 questions that evaluate function, family, leisure, and autonomy. Each question is self-filled and scored from 0 (very unhappy) to 3 (very happy), and the maximum achievable score is 78. The instrument was originally proposed by Manificat and Dazord\[[@pone.0194731.ref045]\] and translated and validated for Brazilian Portuguese by Assumpção et al\[[@pone.0194731.ref046]\].

3.  Child Depression Inventory: This self-administered instrument was designed for children aged 7 to 17 years to assess the presence and severity of depressive symptoms. It is composed of 20 items scored on a Likert scale from 0 to 2 points according to the symptoms presented in the past 2 weeks as follows: 0 (no symptoms); 1 (mild symptoms); and 2 (severe symptoms). The instrument was proposed by Kovacs\[[@pone.0194731.ref047]\], and the version adapted and validated for Brazilian Portuguese by Golfeto et al\[[@pone.0194731.ref048]\] was used.

4.  Adapted Brunel Mood Scale: The adaptation of the Brunel Mood Scale (BRUMS) created by Terry and Lane\[[@pone.0194731.ref049]\] and validated for Brazilian Portuguese by Rohlfs et al\[[@pone.0194731.ref050]\] was used for the self-evaluation of the children\'s moods. Items 2, 6, 7, 10, 11, 12, 13, 14, 15, 19, 20, 21, and 22 were used and scored by the participants using a Likert scale ranging from 0 (not at all) to 4 (extremely).

5.  Faces Pain Scale: This self-applied instrument is used to measure the intensity of perceived pain in children. It is composed of six horizontal faces expressing different degrees of pain. The child chooses the face that best represents his/her degree of pain. The instrument was proposed by Hicks et al\[[@pone.0194731.ref051]\] and translated and validated for Brazilian Portuguese by Silva and Thuler\[[@pone.0194731.ref052]\].

6.  AAT Assessment Questionnaire: This instrument was prepared by the authors to evaluate the participants\' impressions of the AAT programme. It consisted of five questions, namely: i) *\"Did you like playing with the dog in the hospital*?; ii) *Do you think that the activities with the dog helped your treatment?*; iii) *What did you think about spending time with the dog?*; iv) *Do you think it would be nice to always have a dog in the hospital?*; and v) *Would you suggest this activity with the dog to your friends?*.

The following instruments were used to evaluate the outcomes in caregivers:

1.  State-Trait Anxiety Inventory: This other-evaluation instrument is used to quantify subjective components related to anxiety. It consists of 34 items that describe children\'s behaviour or problems. The items were scored by parents or guardians according to the child\'s degree of suffering on a scale ranging from 0 (absent) to 3 (always). The instrument was developed by Spielberger\[[@pone.0194731.ref053]\] and adapted and validated for Brazilian Portuguese by Silva et al\[[@pone.0194731.ref054]\].

2.  Brunel Mood Scale: This self-applied tool was originally developed by Terry and Lane\[[@pone.0194731.ref039]\] and validated for Brazilian Portuguese by Rohlfs\[[@pone.0194731.ref050]\]. It is composed of 24 items scored using a five-point Likert scale ranging from 0 (not at all) to 4 (extremely). This instrument was completed by the caregivers, who answered the items according to the child\'s mood.

3.  Sociodemographic and Clinical Identification Questionnaire: This instrument was constructed for the present study to collect data on the sociodemographic and clinical characteristics of the sample.

Additionally, the blood pressure and heart rate were measured using the BP3ABOH-G-Tech semi-automatic pressure meter appropriate for the participant's age.

Data collection {#sec007}
---------------

Initially, the nursing team contacted the eligible patients and subsequently their caregivers after evaluation of the children by the responsible physician. Children who met the inclusion and exclusion criteria and their parents signed consent and assent forms and were included in the study. Before the start of the first AAT session, the participants and their caregivers completed the instruments described above with the help of a member of the research team trained for this purpose. The heart rate and blood pressure were also measured. At the end of the programme (i.e., end of the third session), the participants and their caregivers filled out the same instruments again, and the physiological parameters were re-measured.

Data analysis {#sec008}
-------------

The data were manually entered into a database and analysed using the Statistical Package for the Social Sciences software (IBM SPSS Statistics 18). Sociodemographic and clinical characteristics were analysed using descriptive statistics. The evaluations before and after the AAT programme were compared using non-parametric statistics with the Wilcoxon test. The size of the effect of the differences within groups was calculated using Cohen's d, with four sizes being described as follows\[[@pone.0194731.ref055]\]: small (≤ 0.2); medium (0.2--0.5); large (0.5--1.0); and very large (\> 1). A level of significance of p \< 0.05 was considered for all analyses.

Results {#sec009}
=======

The sociodemographic and clinical characteristics of the study sample are shown in [Table 1](#pone.0194731.t001){ref-type="table"}.

10.1371/journal.pone.0194731.t001

###### Sociodemographic and clinical characteristics of the study sample.

![](pone.0194731.t001){#pone.0194731.t001g}

  Variables                           N             \%
  ----------------------------------- ------------- ------
  ***Sex***                                         
  *Female*                            14            58.3
  *Male*                              10            41.7
  ***Age***                                         
  *Mean (SD)*                         8.58 (1.98)   
  ***Education***                                   
  *Illiterate*                        4             16.7
  *Can read and write*                5             20.8
  *Incomplete elementary education*   15            62.5
  ***Duration of therapy***                         
  *Mean (SD)--months*                 11.2 (16.7)   
  *Median--months*                    8.5           
  *Minimum/Maximum--months*           1/65          
  ***Treatment period***                            
  *≤ 30 days*                         6             24.7
  *\> 30 days*                        18            75.3

SD = standard deviation; N = number of individuals in the sample; % = percentage of the sample

The sample had a higher predominance of girls (58%), with a mean age of 8.58 years (range: 6 to 12 years). The most common types of tumours were Ewing\'s sarcoma (20.8%) and rhabdomyosarcoma (12.4%). In addition, 16.4% of the children presented allergies, but this condition did not prevent their participation in the programme, and none of the evaluated children had severe mental or cognitive problems.

Tables [2](#pone.0194731.t002){ref-type="table"} and [3](#pone.0194731.t003){ref-type="table"} show the results of the studied variables before and after the AAT programme.

10.1371/journal.pone.0194731.t002

###### The children's clinical and physiological indicators before and after completion of the AAT programme (n = 24).

![](pone.0194731.t002){#pone.0194731.t002g}

  ----------------------------------------------------------------------------------------------------------------------------------------
  Variables                             Pre-AAT\         Post-AAT\        P-value^(A)^                                 *Effect Size* (d)
                                        Mean (SD)        Mean (SD)                                                     
  ------------------------------------- ---------------- ---------------- -------------------------------------------- -------------------
  ***Heart rate (bpm)***                103.42 (16.32)   109.42 (18.51)   0.121                                        0.668

  ***Blood pressure (mmHg)***                                                                                          

  *Minimum*                             63.75 (8.93)     61.04 (12.91)    0.153                                        --0.624

  *Maximum*                             97.92 (9.55)     95.57 (18.19)    0.573                                        --0.237

  ***Presence of pain***                                                                                               

  *Faces Pain Scale*                    0.41 (1.01)      0.08 (0.40)      0.046[\*](#t002fn005){ref-type="table-fn"}   --0.894

  ***Mood (adapted from the BRUMS)***                                                                                  

  *Lively*                              3.38 (0.87)      3.58 (0.83)      0.248                                        0.485

  *Downhearted*                         0.21 (0.58)      0.04 (0.20)      0.194                                        --0.550

  *Annoyed*                             0.50 (1.18)      0 (0)            0.041[\*](#t002fn005){ref-type="table-fn"}   --0.917

  *Sleepy*                              0.54 (1.02)      0.63 (1.09)      0.951                                        0.025

  *Angry*                               0.33 (0.96)      0.13 (0.61)      0.102                                        --0.707

  *Miserable*                           0.17 (0.38)      0.04 (0.20)      0.180                                        --0.570

  *Anxious*                             3.12 (1.51)      2.71 (1.65)      0.373                                        --0.370

  *Worried*                             0.46 (0.93)      0.50 (1.25)      0.887                                        0.058

  *Active*                              3.00 (1.41)      2.75 (1.70)      0.584                                        --0.225

  *Angry*                               0.17 (0.63)      0.13 (0.44)      0.854                                        --0.075

  *Energetic*                           3.50 (1.02)      3.04 (1.39)      0.209                                        --0.531

  *Tired*                               0.42 (0.83)      0.50 (0.88)      0.762                                        0.124

  *Bad-tempered*                        0.25 (0.67)      0.08 (0.40)      0.336                                        --0.401

  ***Child Stress (ESI)***              38.29 (17.75)    30.25 (14.75)    0.005[\*](#t002fn005){ref-type="table-fn"}   --1.404

  ***Quality of life (AUQEI)***         53.63 (6.96)     52.88 (8.00)     0.558                                        0.241

  *Autonomy*                            10.88 (3.17)     10.92 (2.45)     0.895                                        0.053

  *Leisure*                             15.13 (2.25)     14.88 (1.96)     0.692                                        --0.162

  *Function*                            12.25 (3.31)     12.33 (2.91)     0.835                                        0.085

  *Family*                              15.38 (2.41)     14.75 (2.94)     0.206                                        --0.535

  ***Depression (CDI)***                10.13 (5.64)     8.08 (4.85)      0.069                                        --0.801
  ----------------------------------------------------------------------------------------------------------------------------------------

AUQEI = Quality of Life Evaluation Scale; BRUMS = Brunel Mood Scale, adapted; CDI = Child Depression Inventory

\(A\) Wilcoxon\'s test

SD = standard deviation; ESI = Child Stress Symptoms Inventory

\(d\) sample size

\*Significant difference

bpm = beats per minute; mmHg = millimetre of mercury.

10.1371/journal.pone.0194731.t003

###### The caregivers' clinical indicators before and after completion of the AAT programme (n = 24).

![](pone.0194731.t003){#pone.0194731.t003g}

  Variables                        Pre-AAT         Post-AAT        P-value ^(A)^                                *Effect size* (d)
  -------------------------------- --------------- --------------- -------------------------------------------- -------------------
  ***Anxiety (STAI)***             32.04 (16.51)   26.04 (11.85)   0.007[\*](#t003fn002){ref-type="table-fn"}   --1.312
  ***Mood (BRUMS---Subscales)***                                                                                
  *Anger*                          3.38 (4.16)     2.08 (3.56)     0.080                                        --0.764
  *Mental confusion*               3.54 (3.36)     1.71 (2.24)     0.006[\*](#t003fn002){ref-type="table-fn"}   --1.350
  *Fatigue*                        2.42 (3.26)     1.21 (1.86)     0.136                                        --0.639
  *Tension*                        4.75 (3.76)     2.21 (2.06)     0.006[\*](#t003fn002){ref-type="table-fn"}   --1.361
  *Depression*                     2.17 (3.51)     0.83 (1.58)     0.077                                        --0.774
  *Vigour*                         9.83 (3.50)     10.38 (3.05)    0.726                                        0.144

BRUMS = Brunel Mood Scale; SD = standard deviation; STAI = State-Trait Anxiety Inventory

\*Significant difference

\(A\) Wilcoxon\'s test

\(d\) sample size.

Among the children, significant improvement was observed in the pain levels (p = 0.046, d = --0.894), irritation (p = 0.041, d = --0.917), and stress (p = 0.005, d = --1.404), and a tendency towards a decrease was observed for depressive symptoms (p = 0.069; d = --0.801) with large or very large effect sizes. No significant changes in the physiological indicators were observed.

Among the caregivers, significant improvement was observed in the indicators of the Brunel Mood Scale, including anxiety (p = 0.007; d = --1,312), stress (p = 0.006; d = --1.350), and mental confusion (p = 0.006; d = --1.361) (the latter included the items uncertain, muddled, anxious, and worried), and the effect size was classified as very large. There was a tendency towards a decrease in the rate of depression (p = 0.077; d = --0.774). These data are shown in [Table 3](#pone.0194731.t003){ref-type="table"}.

Notably, no complications were observed during the study period for the patients and dogs, and no association was found between worsening of the clinical status of the children and the proposed therapy according to the medical evaluation. Furthermore, the therapy dogs did not show any signs of stress during the study.

Discussion {#sec010}
==========

AAT is an innovative therapeutic modality that has a positive impact on different psychological and physiological variables independent of the target public and the therapeutic context (hospitalized adults\[[@pone.0194731.ref019]--[@pone.0194731.ref021]\], emergency medicine\[[@pone.0194731.ref017]\], oncology\[[@pone.0194731.ref022]--[@pone.0194731.ref029]\], cardiology\[[@pone.0194731.ref030]\], psychiatry\[[@pone.0194731.ref031]--[@pone.0194731.ref033]\], and hospital paediatrics\[[@pone.0194731.ref034]--[@pone.0194731.ref038]\]). An example is better adaptation to the hospital setting and a reduction in stress, anxiety, depressive symptoms, and cortisol levels\[[@pone.0194731.ref056]--[@pone.0194731.ref062]\].

Therefore, there has been high acceptance of this therapy as a coadjuvant strategy for the management of different medical conditions by medical teams in recent years. Paediatric oncology is inserted into this context, because the diagnosis and treatment of childhood cancer causes physical and emotional suffering for children and increases their vulnerability to the development of psychological disorders, which may directly or indirectly affect their general clinical condition.

Previous studies in Canada have described pilot procedures and the results of an AAT programme for children with cancer\[[@pone.0194731.ref027],[@pone.0194731.ref028]\]. This programme was designed to assist children younger than 15 years of age under treatment for haematological and solid tumours. The interventions lasted 12 months, and children who attended the AAT sessions could not present allergies, severe neutropaenia, recent surgery, use of invasive devices, or aggressive behaviour. The authors reported that the benefits of AAT in this context were evidenced by the qualitative perception/evaluation by the caregivers and hospital staff, including improved adaptation to the hospital setting, increased appetite, pain relief, acceptance of invasive procedures, increased sensation of well-being, less suffering, and increased motivation. Considering the positive indicators reported by this research group and the absence of quantitative studies in this context, the objective of the present study was to measure the effects of AAT on psychosocial and physiological parameters of paediatric oncology patients.

The first challenge and a factor that set this study apart was the proposal of a systematic protocol with clear and rigorous inclusion and exclusion criteria for the target patients of the therapy as well as the care to be taken in terms of the hospital environment and therapy animals. This protocol was developed in cooperation with a nosocomial infection control team specialized in oncology. The programme had high acceptance by the hospital staff as a whole, and its execution was feasible. Moreover, no complications that could endanger the health of the patients and animals were observed.

These findings corroborate those of previous studies, which reported the safety of the use of AAT in hospitals when care was taken in the indication and inclusion of patients in the intervention\[[@pone.0194731.ref014],[@pone.0194731.ref027]--[@pone.0194731.ref029],[@pone.0194731.ref034],[@pone.0194731.ref036]--[@pone.0194731.ref039],[@pone.0194731.ref063],[@pone.0194731.ref064]\].

Consistent with the findings of previous studies, our results indicated improvement in pain and psychological parameters (irritation, stress, anxiety, mental confusion, and tension) of the children undergoing outpatient oncological treatment as perceived by the caregivers and children, with significant effect sizes.

The improvement observed after participation in three AAT sessions may be directly related to the benefits of the human-animal relationship, which favours psychological and endocrine changes in the human body. Previous studies have shown that visual communication and touching animals can trigger the release of various substances in the human body, including oxytocin, endorphins, and serotonin, and reduce the baseline cortisol level\[[@pone.0194731.ref048],[@pone.0194731.ref049],[@pone.0194731.ref065]--[@pone.0194731.ref074]\]. These hormones and cytokines in combination may contribute to a reduction of pain, anxiety, and stress and increase the sensation of pleasure and relaxation by children undergoing cancer treatment.

These results can also be explained from the perspective of interspecies relations, because there is no competition and instead there is a type of mutualism that justifies the increase in communication and social relations. The formation of emotional bonds and ties with animals makes their company enjoyable, especially during treatment, and can fill some challenges faced by children during daily oncological treatment, including greater distance from relatives, friends, and school activities and fewer social interactions\[[@pone.0194731.ref054],[@pone.0194731.ref075]\].

The distraction provided by AAT is notable \[i.e., the change in the focus of attention from the disease (symptoms, procedures, limitations, and restrictions) to health\]. AAT was more effective than other leisure activities used in the hospital setting, such as reading, interaction with volunteers, and recreational activities\[[@pone.0194731.ref022],[@pone.0194731.ref023],[@pone.0194731.ref025],[@pone.0194731.ref030],[@pone.0194731.ref070]\], probably due to the specificities of the affiliative and affective relationship between dogs and humans.

In contrast to the results of previous studies, the symptoms of depression did not improve significantly in our study despite the tendency towards a reduction in the symptoms compared to the baseline levels. This result may be because the follow-up period was not sufficient to allow capture of significant changes in this and the other mood and physiological parameters analysed; additionally, the sample size was small, which weakened the power of the statistical tests used and increased the likelihood of type II error (i.e., not identifying differences).

In conclusion, the proposed programme was effective for children in outpatient oncological treatment considering the quantitative effect on the analysed variables, and the selection criteria and safety precautions adopted for the participants, dogs, and hospital environment were adequate considering the acceptance of the programme by the medical team and the lack of complications.

However, this study has the following limitations: 1) a quasi-experimental design^64^ and the absence of a control group and 2) a relatively small sample, which was not statistically estimated and was restricted to specific types of tumours.

Therefore, more studies are necessary to address these limitations and produce robust evidence that can prove the effectiveness of AAT in promoting the physical, mental, and emotional well-being of children undergoing oncological treatment and the humanization of the hospital environment.
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